Gene · 554
Papers2,697
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
861 to 880 of 2,697
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Management of systemic hypotension in term infants with persistent pulmonary hypertension of the newborn: an illustrated review. | Arch Dis Child Fetal Neonatal Ed | 2021 | 33478959 | PubTator, text mining | PubMed |
| The Biology of Vasopressin. | Biomedicines | 2021 | 33477721 | PubTator, text mining | PubMed |
| Predictors of progression in autosomal dominant and autosomal recessive polycystic kidney disease. | Pediatr Nephrol | 2021 | 33474686 | PubTator, text mining | PubMed |
| Preservation of kidney function irrelevant of total kidney volume growth rate with tolvaptan treatment in patients with autosomal dominant polycystic kidney disease. | Clin Exp Nephrol | 2021 | 33471240 | PubTator, text mining | PubMed |
| Selection of Fluorescent, Bioluminescent, and Radioactive Tracers to Accurately Reflect Extracellular Vesicle Biodistribution in Vivo. | ACS Nano | 2021 | 33470092 | PubTator, text mining | PubMed |
| From immune to olfactory expression: neofunctionalization of formyl peptide receptors. | Cell Tissue Res | 2021 | 33452930 | PubTator, text mining | PubMed |
| A metabolically stable apelin-17 analog decreases AVP-induced antidiuresis and improves hyponatremia. | Nat Commun | 2021 | 33436646 | PubTator, text mining | PubMed |
| Vasopressin antagonism in heart failure: a review of the hemodynamic studies and major clinical trials. | Ther Adv Cardiovasc Dis | 2021 | 33435837 | PubTator, text mining | PubMed |
| Pharmacological chaperone action in humanized mouse models of MC4R-linked obesity. | JCI Insight | 2021 | 33434184 | PubTator, text mining | PubMed |
| Genomic analysis of mutations in platelet mitochondria in a case of benzene-induced leukaemia: A case report. | Medicine (Baltimore) | 2021 | 33429764 | PubTator, text mining | PubMed |
| Diabetes Insipidus: A Pragmatic Approach to Management. | Cureus | 2021 | 33425560 | PubTator, text mining | PubMed |
| G protein-coupled receptors: structure- and function-based drug discovery. | Signal Transduct Target Ther | 2021 | 33414387 | PubTator, text mining | PubMed |
| Suppression of Foxo3-Gatm by miR-132-3p Accelerates Cyst Formation by Up-Regulating ROS in Autosomal Dominant Polycystic Kidney Disease. | Biomol Ther (Seoul) | 2021 | 33408288 | PubTator, text mining | PubMed |
| Genetic identification of inherited cystic kidney diseases for implementing precision medicine: a study protocol for a 3-year prospective multicenter cohort study. | BMC Nephrol | 2021 | 33407230 | PubTator, text mining | PubMed |
| Phosphoproteomic identification of vasopressin-regulated protein kinases in collecting duct cells. | Br J Pharmacol | 2021 | 33346914 | PubTator, text mining | PubMed |
| Direct evidence that the GPCR CysLTR2 mutant causative of uveal melanoma is constitutively active with highly biased signaling. | J Biol Chem | 2021 | 33288675 | PubTator, text mining | PubMed |
| Vasopressin associated with renal vascular resistance in adults with longstanding type 1 diabetes with and without diabetic kidney disease. | J Diabetes Complications | 2021 | 33288413 | PubTator, text mining | PubMed |
| Compartmentalized GPCR Signaling from Intracellular Membranes. | J Membr Biol | 2021 | 33231722 | PubTator, text mining | PubMed |
| Integration of transcriptomic, proteomic and metabolomic data to reveal the biological mechanisms of AAI injury in renal epithelial cells. | Toxicol In Vitro | 2021 | 33212167 | PubTator, text mining | PubMed |
| Prediction factors of tolvaptan effectiveness in patients with refractory ascites complicated with hepatocellular carcinoma. | Eur J Gastroenterol Hepatol | 2021 | 33196517 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/554/papers?page=44